2022
DOI: 10.3389/fphar.2022.891801
|View full text |Cite
|
Sign up to set email alerts
|

Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI

Abstract: Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. We investigated, in a highly translatable animal model, whether oral supplementation with spirulina protects against the deleterious effects triggered by ST-elevation MI (STEMI).Methods: Pigs were fed a regular diet supplemented with spirulina (1 g/animal/bid) or p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 51 publications
0
2
0
Order By: Relevance
“…This effect is achieved through antioxidative, anti-inflammatory, and anti-apoptotic mechanisms, leading to a reduction in infarction size and improved cardiac function. Spirulina supplementation appears to be safe and may offer a straightforward approach to counteracting detrimental mechanisms triggered during ST-elevation myocardial infarction (STEMI), potentially enhancing myocardial salvage in the setting of myocardial infarction (MI) (Vilahur et al, 2022) In a study, two lyophilized peptides from Spirulina digestion were orally administered to SHR rats. The peptides were found to reduce blood pressure for up to 8 hours after supplementation, outperforming captopril.…”
Section: Cardio-protec Ve Effectmentioning
confidence: 99%
“…This effect is achieved through antioxidative, anti-inflammatory, and anti-apoptotic mechanisms, leading to a reduction in infarction size and improved cardiac function. Spirulina supplementation appears to be safe and may offer a straightforward approach to counteracting detrimental mechanisms triggered during ST-elevation myocardial infarction (STEMI), potentially enhancing myocardial salvage in the setting of myocardial infarction (MI) (Vilahur et al, 2022) In a study, two lyophilized peptides from Spirulina digestion were orally administered to SHR rats. The peptides were found to reduce blood pressure for up to 8 hours after supplementation, outperforming captopril.…”
Section: Cardio-protec Ve Effectmentioning
confidence: 99%
“…SP has abundant contents of the macro- and micronutrients, and therefore, it is used to produce safe nutritional and medicinal compounds [ 3 , 4 ]. It could be simply harvested and commercially processed into appropriate forms to be used as human and animal nutrition [ 5 , 6 , 7 , 8 , 9 ]. SP comprises high levels of protein (50–70%), carbohydrates (15–20%), lipids (5–7%), minerals (6–9%), and vitamins (1–4%) [ 1 , 10 ].…”
Section: Introductionmentioning
confidence: 99%